Tempero Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$77M
- Investors
-
7
Tempero Bio General Information
Description
Developer of transformative therapies designed for treating and preventing substance use disorders. The company offers a potent, orally available metabotropic glutamate receptor negative allosteric modulator (NAM) that regulates neural signaling, with investigations targeting conditions such as cocaine and alcohol use disorders, enabling doctors to support patients in overcoming dependencies and enhancing overall health outcomes.
Contact Information
Website
www.temperobio.comCorporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Corporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Tempero Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 05-Nov-2025 | $77M | Completed | Clinical Trials - Phase 2 | ||
| 3. Early Stage VC (Series A2) | 02-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A1) | $5.53M | $5.53M | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Tempero Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 1,999,000 | $0.000100 | 2% | $3.07 | $3.07 | 1x | $3.07 | 5.87% |
| Series A-1 | 6,500,000 | $0.000100 | 2% | $3.08 | $3.08 | 1x | $3.08 | 19.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tempero Bio Patents
Tempero Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025521621-A | Methods for treating substance use disorders using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulators - patents.com | Pending | 24-Jun-2022 | ||
| AU-2023289075-A1 | Methods of treating substance use disorder with 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulators | Inactive | 24-Jun-2022 | ||
| EP-4543453-A1 | Methods of treating substance use disorder with 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulators | Inactive | 24-Jun-2022 | ||
| EP-4543453-A4 | Methods of treating substance use disorder with 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulators | Inactive | 24-Jun-2022 | ||
| US-20250249001-A1 | Methods of treating substance use disorder with 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulators | Inactive | 24-Jun-2022 | A61K31/506 |
Tempero Bio Signals
Tempero Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 8VC | Venture Capital | Minority | ||
| Khosla Ventures | Venture Capital | Minority | ||
| Palo Santo | Venture Capital | Minority | ||
| SymBiosis (Bentonville) | Venture Capital | Minority | ||
| Aditum Bio | Venture Capital | Minority |
Tempero Bio FAQs
-
When was Tempero Bio founded?
Tempero Bio was founded in 2020.
-
Where is Tempero Bio headquartered?
Tempero Bio is headquartered in Oakland, CA.
-
What is the size of Tempero Bio?
Tempero Bio has 10 total employees.
-
What industry is Tempero Bio in?
Tempero Bio’s primary industry is Drug Discovery.
-
Is Tempero Bio a private or public company?
Tempero Bio is a Private company.
-
What is the current valuation of Tempero Bio?
The current valuation of Tempero Bio is .
-
What is Tempero Bio’s current revenue?
The current revenue for Tempero Bio is .
-
How much funding has Tempero Bio raised over time?
Tempero Bio has raised $88.6M.
-
Who are Tempero Bio’s investors?
8VC, Khosla Ventures, Palo Santo, SymBiosis (Bentonville), and Aditum Bio are 5 of 7 investors who have invested in Tempero Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process